Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII Technical Analysis Summary (NASDAQ)

Analyze DMII on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

DMII●NASDAQ
Financial ServicesFinancial - Conglomerates
$10.17
$0.005(0.05%)
U.S. Market opens in 18h 43m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMII Technical Analysis Summary (NASDAQ)

Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Bullish (RSI: 62.72)
Trend Strength:Very Strong (ADX: 54.13)
Volatility:Low (ATR: 0.02)
Support/Resistance:$10.13 – $10.19 (Bollinger Bands)

Technical conditions suggest Drugs Made In America Acquisition II Corp. Ordinary Shares on the NASDAQ is awaiting a decisive move. Overall, Drugs Made In America Acquisition II Corp. Ordinary Shares remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 62.72

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 56.48

Neutral
Mid-range signal with no clear trend.

Williams %R: -37.50

Bullish
Buying pressure building steadily.

Rate of Change (ROC): 0.39

Neutral
Price change is minimal.

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 0.01

Bullish
Bullish, trend momentum is strengthening.

ADX: 54.13

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.02

Low
Low volatility, stable price action.

CCI (14): 110.06

Bearish Risk
Bearish risk, overbought levels suggest caution.

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$10.19
Middle Band (SMA 20)
$10.16
Lower Band
$10.13
Current Position
Within Bands

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares trades closer to resistance, supported by stronger momentum within bands.

Keltner Channels
Upper Channel
$10.19
Middle Line (EMA 20)
$10.16
Lower Channel
$10.12
Squeeze Status
Squeeze On

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume-723.57K
Money Flow Index73.01Bullish, inflows support continued momentum.
Relative Vigor Index32.46Bearish, price momentum favors sellers.

Overall Takeaway:DMII shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Drugs Made In America Acquisition II Corp. Ordinary Shares stock shows a Strong Buy signal — momentum and trend strength are firmly positive, supported by stable volatility.

(NASDAQ: DMII) Technical Analysis FAQ